JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2022-06-28 KKKwish

偏重的研究方向：流行病学;瘢痕
经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？

201 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-06-30 ms1000000163439783

刚投了个review，希望至少能得到外审意见

295 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2022-06-21 ms8000002026250184

5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。

179 0

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-01-14 阿呆666

昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下

361 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2022-05-21 小桥流水meitong

一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。

177 0

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-12-03 ms6000001037448610

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：性病;皮肤病
经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。

257 0

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-11-19 ms8000001304230869

投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。

200 0

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-04-30 浩瀚林海

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投了个case，10天就拒了，速度还挺快的

165 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2021-05-12 ms2000002096194073

哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1229121, encodeId=3fc9122912143, content=偏重的研究方向：流行病学;瘢痕 经验分享：6.3投稿，过了两三天under review，至今6.28还是under review，请问各位大佬有没有希望呀，流行病学研究友好吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f005510445, createdName=KKKwish, createdTime=Tue Jun 28 11:15:28 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978331, encodeId=734d9e8331d2, content=刚投了个review，希望至少能得到外审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c6955495673, createdName=ms1000000163439783, createdTime=Wed Jun 30 21:27:23 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227801, encodeId=8d70122e80136, content=5月31号投稿，under review1天就recommendation，预感就不好了，6月21号给了reject。速度还是可以，不拖泥带水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f126505064, createdName=ms8000002026250184, createdTime=Tue Jun 21 18:39:10 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916485, encodeId=d77591648592, content=昨天看的时候才Under review 今天一早就变成了waiting recommendation,是不是希望不大了，麻烦前辈们看见能帮忙解答一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKD9B92ImKpbB5AMzttjBlz3zFia0YQ8EV4xat9nbXWzZAe2d3qEX5XkWW0nIWa1gzI1fRBFRIRQpA/132, createdBy=ef252494787, createdName=阿呆666, createdTime=Thu Jan 14 12:00:02 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221352, encodeId=da3d12213526b, content=一个月后被拒了，但是给了审稿意见。其中一个专家给了10来条很中肯的意见。Under review两个星期，waiting recommendation两个星期，awaiting decision三四天。还是值得试试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=91315513120, createdName=小桥流水meitong, createdTime=Sat May 21 10:35:07 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076523, encodeId=05fc10e65231f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：性病;皮肤病 经验分享：现在很难中了，不建议投稿。对文章的质量要求较高，初审两个月，给了意见（没什么具体建议，就是文章没有润色说写的不好，建议润色），但是决定权在编辑，说不缺稿源直接拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/7c81d4f6565d4313bbf41259386537d4/737b970fb5184554a7b3aabca85e050b.jpg, createdBy=a51a5492900, createdName=ms6000001037448610, createdTime=Fri Dec 03 11:40:09 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071597, encodeId=88f610e15971b, content=投了个letter，2天under review ，2天后awaiting decision，1天后拒稿。应该是没外审就毙了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1d35433427, createdName=ms8000001304230869, createdTime=Fri Nov 19 02:01:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961991, encodeId=52a096199146, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投了个case，10天就拒了，速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5fd1737063, createdName=浩瀚林海, createdTime=Fri Apr 30 19:37:51 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964925, encodeId=330296492592, content=哪位大神知道这个杂志接收关于皮肤基础研究、分子机制类的文章嘛？十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d4c5428125, createdName=ms2000002096194073, createdTime=Wed May 12 15:54:06 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861649, encodeId=b25a86164904, content=审稿速度:2.0 经验分享：审了2个月，拒了。然而也没有给出很好的建议。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Tue Jun 09 21:15:54 CST 2020, time=2020-06-09, status=1, ipAttribution=)]

2020-06-09 ms7253200455804543

审稿速度:2.0
经验分享：审了2个月，拒了。然而也没有给出很好的建议。

190 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务